Taimei Technology, a Chinese cloud-based software provider that serves pharmaceutical companies and clinical research organizations (CROs), announced on Friday the completion of Series E and Series E+ rounds of financing at 1.5 billion yuan ($212 million).
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
